Nisa Leung’s Aulis Capital closes $200M debut fund for cross-border biotech
Thursday, November 5, 2026 · first reported by Dealroom
Aulis Capital closed its $200 million debut fund focused on cross-border biotech.
- Firm
- Aulis Capital
- Fund
- Aulis Capital debut fund
- Size
- $200M
- Stage
- Final close
- People
- Nisa Leung
- Asset class
- Hedge funds
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
See an error?
Coverage
1 source- Janus Henderson and Centrifuge Launch Blockchain-Native Fund Tracking the Nasdaq-100 Index (JQQQ)Benzinga
- Walleye Capital restructures equity long/short business following 5.9% October lossHedgeweek +1
- Millennium withdraws $1.5bn from external hedge funds following lossesHedgeweek +1
- Five credit portfolio managers depart Brevan Howard amid market volatilityHedgeweek
- Icahn-Backed Firm Paying $4.2B For Marathon Oil AssetsLaw360
- Former Moore Capital manager to return external capital from Room40Hedgeweek
Got news? Send it to us →